肿瘤肾脏切除在转移性肾细胞癌治疗中的意义  

The role of cytoreductive nephrectomy in the treatment of metastatic renal cell carcinoma

作　　者：潘铁军[1] 周宇[1] 

机构地区：[1]广州军区武汉总医院泌尿外科,湖北武汉430070

出　　处：《现代泌尿外科杂志》2014年第2期80-82,共3页Journal of Modern Urology

摘　　要：转移性肾细胞癌的治疗是肾癌治疗的难点。以往认为转移性肾细胞癌切除肿瘤原发灶是没有意义的。但随着肾癌免疫治疗和靶向治疗的发展,越来越多的证据证明肿瘤肾脏切除在转移性肾细胞癌的治疗中有着重要意义。本文通过复习相关文献对肿瘤肾脏切除术在转移性肾细胞癌治疗中的意义作简单介绍。The therapy of metastatic renal cell carcinoma was complicated. Former studies indicated that cytoreductive ne- phrectomy was not useful. But with the development of immunotherapy and target therapy,more and more evidence came up to convince the role of cytoreductive nephrectomy in treatment. We reviewed in this paper the literature on cytoreductive nephrectomy in the treatment of metastatic renal cell carcinoma.

关 键 词：转移性肾细胞癌 肿瘤肾脏切除术 靶向治疗 免疫治疗 保留肾单位手术 

分 类 号：R737.11[医药卫生—肿瘤]